Global Artemether Market

Artemether Comprehensive Study by Type (Micro Orgo Che (india), Ambrosia Drugs Pvt. (india), Sigmak Lifesciences (india)), Sales Channels (Online Sales Channel {Company Website, E-Commerce Platform}, Offline Sales Channels {Company store outlet, and medical Stores}), Mode of Administration (Oral, Intravenous Route, Intramuscular Route, Subcutaneous Route, Rectal Route, Vaginal Route, Inhaled Route) Players and Region - Global Market Outlook to 2028

Artemether Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Global Artemether Market Overview:
Artemether is a derivative of artemisinin in which the lactone has been converted to the corresponding lacto methyl ether. For the treatment of multi-drug resistant strains of falciparum malaria. It has a role as an antimalarial it is used in combination with lumefantrine as an antimalarial. The injectable form is specifically for severe malaria. It is given by intramuscular way of administration. This combination is in medical use since 1992. and The Food and Drug Administration (FDA) has approved artemether-lumefantrine (Coartem) for the treatment of uncomplicated Plasmodium falciparum malaria in adults, children and infants weighing at least 5 kilograms in 2009 developed by Novartis Pharmaceutical company

AttributesDetails
Study Period2018-2028
Base Year2022
Forecast Period2023-2028
Historical Period2018-2022
UnitValue (USD Million)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


Influencing Trend:
Chinese Companies has Major Hold on Artemether Manufacturing Market

Market Growth Drivers:
P. falciparum infection mostly accounted for 99.7 percent estimated in African Region, 50 percent in the South-East Asia Region, 71 percent in the Eastern Mediterranean and 65 percent in the Western Pacific

Challenges:
Malaria cases has shown that the scourge of malaria remains prominent among pregnant women and young children in Africa, but manufacturing companies are in china, so the prizes of the drugs have bear with transport charges

Restraints:
For the clinical development of the drug there are Male and older female FGD participants tended to describe physical methods, but as a restraint, the disease more affecting to the younger and older children and pregnant women take their medication

Opportunities:
Most preferable mode of administration of drug is oil-based intramuscular injection. Market opportunities include limited availability, low quality, lack of information, and high costs of access

Competitive Landscape:
Artemether market is a fragmented market due to the presence of various players. Companies are focusing on developing different combination to improve quality, enhances and promotes performance. The companies are coming up with partnerships or agreements along with planning strategic activities such as partnerships, product launch, mergers, and acquisitions which will help them to sustain in the market and maintain their competitive edge.
Some of the key players profiled in the report are Novartis Pharmaceutical Company (Switzerland), Chengdu Chenlv Herb Co.,Ltd. (China), Cipla (India), Huvepharma Italia (Italy), Sichuan Xieli (China), Shaoxing Hantai Pharma (China), DKSH (Switzerland), Ipca Labs. (India) and Vital Laboratories Pvt. Ltd. (India). Analyst at AMA Research see China Players to retain maximum share of Global Artemether market by 2028. Considering Market by Sales Channels, the sub-segment i.e. Online Sales Channel {Company Website, E-Commerce Platform} will boost the Artemether market. Considering Market by Mode of Administration, the sub-segment i.e. Oral will boost the Artemether market.

Latest Market Insights:
In November 2022, Novartis and MMV announced to Phase 3 development for the treatment of patients with acute uncomplicated malaria due to Plasmodium falciparum of ganaplacide/lumefantrine- solid dispersion formulation.

As main leading company Novartis to double China business by 2025, as a result the manufacturing and prising of the drugs could be affected in near years

What Can be Explored with the Artemether Market Study
 Gain Market Understanding
 Identify Growth Opportunities
 Analyze and Measure the Global Artemether Market by Identifying Investment across various Industry Verticals
 Understand the Trends that will drive Future Changes in Artemether
 Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Artemether market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Artemether market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Hospitals, Medical institutes, Pathology labs, Government Regulatory and Research Organizations, End-Use Industries, Mail order and Direct marketing routes.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.

Report Objectives / Segmentation Covered

By Type
  • Micro Orgo Che (india)
  • Ambrosia Drugs Pvt. (india)
  • Sigmak Lifesciences (india)
By Sales Channels
  • Online Sales Channel {Company Website, E-Commerce Platform}
  • Offline Sales Channels {Company store outlet, and medical Stores}

By Mode of Administration
  • Oral
  • Intravenous Route
  • Intramuscular Route
  • Subcutaneous Route
  • Rectal Route
  • Vaginal Route
  • Inhaled Route

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. P. falciparum infection mostly accounted for 99.7 percent estimated in African Region, 50 percent in the South-East Asia Region, 71 percent in the Eastern Mediterranean and 65 percent in the Western Pacific
    • 3.3. Market Challenges
      • 3.3.1. Malaria cases has shown that the scourge of malaria remains prominent among pregnant women and young children in Africa, but manufacturing companies are in china, so the prizes of the drugs have bear with transport charges
    • 3.4. Market Trends
      • 3.4.1. Chinese Companies has Major Hold on Artemether Manufacturing Market
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Artemether, by Type, Sales Channels, Mode of Administration and Region (value, volume and price ) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Artemether (Value)
      • 5.2.1. Global Artemether by: Type (Value)
        • 5.2.1.1. Micro Orgo Che (india)
        • 5.2.1.2. Ambrosia Drugs Pvt. (india)
        • 5.2.1.3. Sigmak Lifesciences (india)
      • 5.2.2. Global Artemether by: Sales Channels (Value)
        • 5.2.2.1. Online Sales Channel {Company Website, E-Commerce Platform}
        • 5.2.2.2. Offline Sales Channels {Company store outlet, and medical Stores}
      • 5.2.3. Global Artemether by: Mode of Administration (Value)
        • 5.2.3.1. Oral
        • 5.2.3.2. Intravenous Route
        • 5.2.3.3. Intramuscular Route
        • 5.2.3.4. Subcutaneous Route
        • 5.2.3.5. Rectal Route
        • 5.2.3.6. Vaginal Route
        • 5.2.3.7. Inhaled Route
      • 5.2.4. Global Artemether Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Australia
          • 5.2.4.2.6. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Artemether (Volume)
      • 5.3.1. Global Artemether by: Type (Volume)
        • 5.3.1.1. Micro Orgo Che (india)
        • 5.3.1.2. Ambrosia Drugs Pvt. (india)
        • 5.3.1.3. Sigmak Lifesciences (india)
      • 5.3.2. Global Artemether by: Sales Channels (Volume)
        • 5.3.2.1. Online Sales Channel {Company Website, E-Commerce Platform}
        • 5.3.2.2. Offline Sales Channels {Company store outlet, and medical Stores}
      • 5.3.3. Global Artemether by: Mode of Administration (Volume)
        • 5.3.3.1. Oral
        • 5.3.3.2. Intravenous Route
        • 5.3.3.3. Intramuscular Route
        • 5.3.3.4. Subcutaneous Route
        • 5.3.3.5. Rectal Route
        • 5.3.3.6. Vaginal Route
        • 5.3.3.7. Inhaled Route
      • 5.3.4. Global Artemether Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Australia
          • 5.3.4.2.6. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Artemether (Price)
      • 5.4.1. Global Artemether by: Type (Price)
  • 6. Artemether: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Novartis Pharmaceutical Company (Switzerland)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Chengdu Chenlv Herb Co.,Ltd. (China)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Cipla (India)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Huvepharma Italia (Italy)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Sichuan Xieli (China)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Shaoxing Hantai Pharma (China)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. DKSH (Switzerland)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Ipca Labs. (India)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Vital Laboratories Pvt. Ltd. (India)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Artemether Sale, by Type, Sales Channels, Mode of Administration and Region (value, volume and price ) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Artemether (Value)
      • 7.2.1. Global Artemether by: Type (Value)
        • 7.2.1.1. Micro Orgo Che (india)
        • 7.2.1.2. Ambrosia Drugs Pvt. (india)
        • 7.2.1.3. Sigmak Lifesciences (india)
      • 7.2.2. Global Artemether by: Sales Channels (Value)
        • 7.2.2.1. Online Sales Channel {Company Website, E-Commerce Platform}
        • 7.2.2.2. Offline Sales Channels {Company store outlet, and medical Stores}
      • 7.2.3. Global Artemether by: Mode of Administration (Value)
        • 7.2.3.1. Oral
        • 7.2.3.2. Intravenous Route
        • 7.2.3.3. Intramuscular Route
        • 7.2.3.4. Subcutaneous Route
        • 7.2.3.5. Rectal Route
        • 7.2.3.6. Vaginal Route
        • 7.2.3.7. Inhaled Route
      • 7.2.4. Global Artemether Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Australia
          • 7.2.4.2.6. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Artemether (Volume)
      • 7.3.1. Global Artemether by: Type (Volume)
        • 7.3.1.1. Micro Orgo Che (india)
        • 7.3.1.2. Ambrosia Drugs Pvt. (india)
        • 7.3.1.3. Sigmak Lifesciences (india)
      • 7.3.2. Global Artemether by: Sales Channels (Volume)
        • 7.3.2.1. Online Sales Channel {Company Website, E-Commerce Platform}
        • 7.3.2.2. Offline Sales Channels {Company store outlet, and medical Stores}
      • 7.3.3. Global Artemether by: Mode of Administration (Volume)
        • 7.3.3.1. Oral
        • 7.3.3.2. Intravenous Route
        • 7.3.3.3. Intramuscular Route
        • 7.3.3.4. Subcutaneous Route
        • 7.3.3.5. Rectal Route
        • 7.3.3.6. Vaginal Route
        • 7.3.3.7. Inhaled Route
      • 7.3.4. Global Artemether Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Australia
          • 7.3.4.2.6. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Artemether (Price)
      • 7.4.1. Global Artemether by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Artemether: by Type(USD Million)
  • Table 2. Artemether Micro Orgo Che (india) , by Region USD Million (2017-2022)
  • Table 3. Artemether Ambrosia Drugs Pvt. (india) , by Region USD Million (2017-2022)
  • Table 4. Artemether Sigmak Lifesciences (india) , by Region USD Million (2017-2022)
  • Table 5. Artemether: by Sales Channels(USD Million)
  • Table 6. Artemether Online Sales Channel {Company Website, E-Commerce Platform} , by Region USD Million (2017-2022)
  • Table 7. Artemether Offline Sales Channels {Company store outlet, and medical Stores} , by Region USD Million (2017-2022)
  • Table 8. Artemether: by Mode of Administration(USD Million)
  • Table 9. Artemether Oral , by Region USD Million (2017-2022)
  • Table 10. Artemether Intravenous Route , by Region USD Million (2017-2022)
  • Table 11. Artemether Intramuscular Route , by Region USD Million (2017-2022)
  • Table 12. Artemether Subcutaneous Route , by Region USD Million (2017-2022)
  • Table 13. Artemether Rectal Route , by Region USD Million (2017-2022)
  • Table 14. Artemether Vaginal Route , by Region USD Million (2017-2022)
  • Table 15. Artemether Inhaled Route , by Region USD Million (2017-2022)
  • Table 16. South America Artemether, by Country USD Million (2017-2022)
  • Table 17. South America Artemether, by Type USD Million (2017-2022)
  • Table 18. South America Artemether, by Sales Channels USD Million (2017-2022)
  • Table 19. South America Artemether, by Mode of Administration USD Million (2017-2022)
  • Table 20. Brazil Artemether, by Type USD Million (2017-2022)
  • Table 21. Brazil Artemether, by Sales Channels USD Million (2017-2022)
  • Table 22. Brazil Artemether, by Mode of Administration USD Million (2017-2022)
  • Table 23. Argentina Artemether, by Type USD Million (2017-2022)
  • Table 24. Argentina Artemether, by Sales Channels USD Million (2017-2022)
  • Table 25. Argentina Artemether, by Mode of Administration USD Million (2017-2022)
  • Table 26. Rest of South America Artemether, by Type USD Million (2017-2022)
  • Table 27. Rest of South America Artemether, by Sales Channels USD Million (2017-2022)
  • Table 28. Rest of South America Artemether, by Mode of Administration USD Million (2017-2022)
  • Table 29. Asia Pacific Artemether, by Country USD Million (2017-2022)
  • Table 30. Asia Pacific Artemether, by Type USD Million (2017-2022)
  • Table 31. Asia Pacific Artemether, by Sales Channels USD Million (2017-2022)
  • Table 32. Asia Pacific Artemether, by Mode of Administration USD Million (2017-2022)
  • Table 33. China Artemether, by Type USD Million (2017-2022)
  • Table 34. China Artemether, by Sales Channels USD Million (2017-2022)
  • Table 35. China Artemether, by Mode of Administration USD Million (2017-2022)
  • Table 36. Japan Artemether, by Type USD Million (2017-2022)
  • Table 37. Japan Artemether, by Sales Channels USD Million (2017-2022)
  • Table 38. Japan Artemether, by Mode of Administration USD Million (2017-2022)
  • Table 39. India Artemether, by Type USD Million (2017-2022)
  • Table 40. India Artemether, by Sales Channels USD Million (2017-2022)
  • Table 41. India Artemether, by Mode of Administration USD Million (2017-2022)
  • Table 42. South Korea Artemether, by Type USD Million (2017-2022)
  • Table 43. South Korea Artemether, by Sales Channels USD Million (2017-2022)
  • Table 44. South Korea Artemether, by Mode of Administration USD Million (2017-2022)
  • Table 45. Australia Artemether, by Type USD Million (2017-2022)
  • Table 46. Australia Artemether, by Sales Channels USD Million (2017-2022)
  • Table 47. Australia Artemether, by Mode of Administration USD Million (2017-2022)
  • Table 48. Rest of Asia-Pacific Artemether, by Type USD Million (2017-2022)
  • Table 49. Rest of Asia-Pacific Artemether, by Sales Channels USD Million (2017-2022)
  • Table 50. Rest of Asia-Pacific Artemether, by Mode of Administration USD Million (2017-2022)
  • Table 51. Europe Artemether, by Country USD Million (2017-2022)
  • Table 52. Europe Artemether, by Type USD Million (2017-2022)
  • Table 53. Europe Artemether, by Sales Channels USD Million (2017-2022)
  • Table 54. Europe Artemether, by Mode of Administration USD Million (2017-2022)
  • Table 55. Germany Artemether, by Type USD Million (2017-2022)
  • Table 56. Germany Artemether, by Sales Channels USD Million (2017-2022)
  • Table 57. Germany Artemether, by Mode of Administration USD Million (2017-2022)
  • Table 58. France Artemether, by Type USD Million (2017-2022)
  • Table 59. France Artemether, by Sales Channels USD Million (2017-2022)
  • Table 60. France Artemether, by Mode of Administration USD Million (2017-2022)
  • Table 61. Italy Artemether, by Type USD Million (2017-2022)
  • Table 62. Italy Artemether, by Sales Channels USD Million (2017-2022)
  • Table 63. Italy Artemether, by Mode of Administration USD Million (2017-2022)
  • Table 64. United Kingdom Artemether, by Type USD Million (2017-2022)
  • Table 65. United Kingdom Artemether, by Sales Channels USD Million (2017-2022)
  • Table 66. United Kingdom Artemether, by Mode of Administration USD Million (2017-2022)
  • Table 67. Netherlands Artemether, by Type USD Million (2017-2022)
  • Table 68. Netherlands Artemether, by Sales Channels USD Million (2017-2022)
  • Table 69. Netherlands Artemether, by Mode of Administration USD Million (2017-2022)
  • Table 70. Rest of Europe Artemether, by Type USD Million (2017-2022)
  • Table 71. Rest of Europe Artemether, by Sales Channels USD Million (2017-2022)
  • Table 72. Rest of Europe Artemether, by Mode of Administration USD Million (2017-2022)
  • Table 73. MEA Artemether, by Country USD Million (2017-2022)
  • Table 74. MEA Artemether, by Type USD Million (2017-2022)
  • Table 75. MEA Artemether, by Sales Channels USD Million (2017-2022)
  • Table 76. MEA Artemether, by Mode of Administration USD Million (2017-2022)
  • Table 77. Middle East Artemether, by Type USD Million (2017-2022)
  • Table 78. Middle East Artemether, by Sales Channels USD Million (2017-2022)
  • Table 79. Middle East Artemether, by Mode of Administration USD Million (2017-2022)
  • Table 80. Africa Artemether, by Type USD Million (2017-2022)
  • Table 81. Africa Artemether, by Sales Channels USD Million (2017-2022)
  • Table 82. Africa Artemether, by Mode of Administration USD Million (2017-2022)
  • Table 83. North America Artemether, by Country USD Million (2017-2022)
  • Table 84. North America Artemether, by Type USD Million (2017-2022)
  • Table 85. North America Artemether, by Sales Channels USD Million (2017-2022)
  • Table 86. North America Artemether, by Mode of Administration USD Million (2017-2022)
  • Table 87. United States Artemether, by Type USD Million (2017-2022)
  • Table 88. United States Artemether, by Sales Channels USD Million (2017-2022)
  • Table 89. United States Artemether, by Mode of Administration USD Million (2017-2022)
  • Table 90. Canada Artemether, by Type USD Million (2017-2022)
  • Table 91. Canada Artemether, by Sales Channels USD Million (2017-2022)
  • Table 92. Canada Artemether, by Mode of Administration USD Million (2017-2022)
  • Table 93. Mexico Artemether, by Type USD Million (2017-2022)
  • Table 94. Mexico Artemether, by Sales Channels USD Million (2017-2022)
  • Table 95. Mexico Artemether, by Mode of Administration USD Million (2017-2022)
  • Table 96. Artemether Sales: by Type(Tons)
  • Table 97. Artemether Sales Micro Orgo Che (india) , by Region Tons (2017-2022)
  • Table 98. Artemether Sales Ambrosia Drugs Pvt. (india) , by Region Tons (2017-2022)
  • Table 99. Artemether Sales Sigmak Lifesciences (india) , by Region Tons (2017-2022)
  • Table 100. Artemether Sales: by Sales Channels(Tons)
  • Table 101. Artemether Sales Online Sales Channel {Company Website, E-Commerce Platform} , by Region Tons (2017-2022)
  • Table 102. Artemether Sales Offline Sales Channels {Company store outlet, and medical Stores} , by Region Tons (2017-2022)
  • Table 103. Artemether Sales: by Mode of Administration(Tons)
  • Table 104. Artemether Sales Oral , by Region Tons (2017-2022)
  • Table 105. Artemether Sales Intravenous Route , by Region Tons (2017-2022)
  • Table 106. Artemether Sales Intramuscular Route , by Region Tons (2017-2022)
  • Table 107. Artemether Sales Subcutaneous Route , by Region Tons (2017-2022)
  • Table 108. Artemether Sales Rectal Route , by Region Tons (2017-2022)
  • Table 109. Artemether Sales Vaginal Route , by Region Tons (2017-2022)
  • Table 110. Artemether Sales Inhaled Route , by Region Tons (2017-2022)
  • Table 111. South America Artemether Sales, by Country Tons (2017-2022)
  • Table 112. South America Artemether Sales, by Type Tons (2017-2022)
  • Table 113. South America Artemether Sales, by Sales Channels Tons (2017-2022)
  • Table 114. South America Artemether Sales, by Mode of Administration Tons (2017-2022)
  • Table 115. Brazil Artemether Sales, by Type Tons (2017-2022)
  • Table 116. Brazil Artemether Sales, by Sales Channels Tons (2017-2022)
  • Table 117. Brazil Artemether Sales, by Mode of Administration Tons (2017-2022)
  • Table 118. Argentina Artemether Sales, by Type Tons (2017-2022)
  • Table 119. Argentina Artemether Sales, by Sales Channels Tons (2017-2022)
  • Table 120. Argentina Artemether Sales, by Mode of Administration Tons (2017-2022)
  • Table 121. Rest of South America Artemether Sales, by Type Tons (2017-2022)
  • Table 122. Rest of South America Artemether Sales, by Sales Channels Tons (2017-2022)
  • Table 123. Rest of South America Artemether Sales, by Mode of Administration Tons (2017-2022)
  • Table 124. Asia Pacific Artemether Sales, by Country Tons (2017-2022)
  • Table 125. Asia Pacific Artemether Sales, by Type Tons (2017-2022)
  • Table 126. Asia Pacific Artemether Sales, by Sales Channels Tons (2017-2022)
  • Table 127. Asia Pacific Artemether Sales, by Mode of Administration Tons (2017-2022)
  • Table 128. China Artemether Sales, by Type Tons (2017-2022)
  • Table 129. China Artemether Sales, by Sales Channels Tons (2017-2022)
  • Table 130. China Artemether Sales, by Mode of Administration Tons (2017-2022)
  • Table 131. Japan Artemether Sales, by Type Tons (2017-2022)
  • Table 132. Japan Artemether Sales, by Sales Channels Tons (2017-2022)
  • Table 133. Japan Artemether Sales, by Mode of Administration Tons (2017-2022)
  • Table 134. India Artemether Sales, by Type Tons (2017-2022)
  • Table 135. India Artemether Sales, by Sales Channels Tons (2017-2022)
  • Table 136. India Artemether Sales, by Mode of Administration Tons (2017-2022)
  • Table 137. South Korea Artemether Sales, by Type Tons (2017-2022)
  • Table 138. South Korea Artemether Sales, by Sales Channels Tons (2017-2022)
  • Table 139. South Korea Artemether Sales, by Mode of Administration Tons (2017-2022)
  • Table 140. Australia Artemether Sales, by Type Tons (2017-2022)
  • Table 141. Australia Artemether Sales, by Sales Channels Tons (2017-2022)
  • Table 142. Australia Artemether Sales, by Mode of Administration Tons (2017-2022)
  • Table 143. Rest of Asia-Pacific Artemether Sales, by Type Tons (2017-2022)
  • Table 144. Rest of Asia-Pacific Artemether Sales, by Sales Channels Tons (2017-2022)
  • Table 145. Rest of Asia-Pacific Artemether Sales, by Mode of Administration Tons (2017-2022)
  • Table 146. Europe Artemether Sales, by Country Tons (2017-2022)
  • Table 147. Europe Artemether Sales, by Type Tons (2017-2022)
  • Table 148. Europe Artemether Sales, by Sales Channels Tons (2017-2022)
  • Table 149. Europe Artemether Sales, by Mode of Administration Tons (2017-2022)
  • Table 150. Germany Artemether Sales, by Type Tons (2017-2022)
  • Table 151. Germany Artemether Sales, by Sales Channels Tons (2017-2022)
  • Table 152. Germany Artemether Sales, by Mode of Administration Tons (2017-2022)
  • Table 153. France Artemether Sales, by Type Tons (2017-2022)
  • Table 154. France Artemether Sales, by Sales Channels Tons (2017-2022)
  • Table 155. France Artemether Sales, by Mode of Administration Tons (2017-2022)
  • Table 156. Italy Artemether Sales, by Type Tons (2017-2022)
  • Table 157. Italy Artemether Sales, by Sales Channels Tons (2017-2022)
  • Table 158. Italy Artemether Sales, by Mode of Administration Tons (2017-2022)
  • Table 159. United Kingdom Artemether Sales, by Type Tons (2017-2022)
  • Table 160. United Kingdom Artemether Sales, by Sales Channels Tons (2017-2022)
  • Table 161. United Kingdom Artemether Sales, by Mode of Administration Tons (2017-2022)
  • Table 162. Netherlands Artemether Sales, by Type Tons (2017-2022)
  • Table 163. Netherlands Artemether Sales, by Sales Channels Tons (2017-2022)
  • Table 164. Netherlands Artemether Sales, by Mode of Administration Tons (2017-2022)
  • Table 165. Rest of Europe Artemether Sales, by Type Tons (2017-2022)
  • Table 166. Rest of Europe Artemether Sales, by Sales Channels Tons (2017-2022)
  • Table 167. Rest of Europe Artemether Sales, by Mode of Administration Tons (2017-2022)
  • Table 168. MEA Artemether Sales, by Country Tons (2017-2022)
  • Table 169. MEA Artemether Sales, by Type Tons (2017-2022)
  • Table 170. MEA Artemether Sales, by Sales Channels Tons (2017-2022)
  • Table 171. MEA Artemether Sales, by Mode of Administration Tons (2017-2022)
  • Table 172. Middle East Artemether Sales, by Type Tons (2017-2022)
  • Table 173. Middle East Artemether Sales, by Sales Channels Tons (2017-2022)
  • Table 174. Middle East Artemether Sales, by Mode of Administration Tons (2017-2022)
  • Table 175. Africa Artemether Sales, by Type Tons (2017-2022)
  • Table 176. Africa Artemether Sales, by Sales Channels Tons (2017-2022)
  • Table 177. Africa Artemether Sales, by Mode of Administration Tons (2017-2022)
  • Table 178. North America Artemether Sales, by Country Tons (2017-2022)
  • Table 179. North America Artemether Sales, by Type Tons (2017-2022)
  • Table 180. North America Artemether Sales, by Sales Channels Tons (2017-2022)
  • Table 181. North America Artemether Sales, by Mode of Administration Tons (2017-2022)
  • Table 182. United States Artemether Sales, by Type Tons (2017-2022)
  • Table 183. United States Artemether Sales, by Sales Channels Tons (2017-2022)
  • Table 184. United States Artemether Sales, by Mode of Administration Tons (2017-2022)
  • Table 185. Canada Artemether Sales, by Type Tons (2017-2022)
  • Table 186. Canada Artemether Sales, by Sales Channels Tons (2017-2022)
  • Table 187. Canada Artemether Sales, by Mode of Administration Tons (2017-2022)
  • Table 188. Mexico Artemether Sales, by Type Tons (2017-2022)
  • Table 189. Mexico Artemether Sales, by Sales Channels Tons (2017-2022)
  • Table 190. Mexico Artemether Sales, by Mode of Administration Tons (2017-2022)
  • Table 191. Artemether: by Type(USD/Units)
  • Table 192. Company Basic Information, Sales Area and Its Competitors
  • Table 193. Company Basic Information, Sales Area and Its Competitors
  • Table 194. Company Basic Information, Sales Area and Its Competitors
  • Table 195. Company Basic Information, Sales Area and Its Competitors
  • Table 196. Company Basic Information, Sales Area and Its Competitors
  • Table 197. Company Basic Information, Sales Area and Its Competitors
  • Table 198. Company Basic Information, Sales Area and Its Competitors
  • Table 199. Company Basic Information, Sales Area and Its Competitors
  • Table 200. Company Basic Information, Sales Area and Its Competitors
  • Table 201. Artemether: by Type(USD Million)
  • Table 202. Artemether Micro Orgo Che (india) , by Region USD Million (2023-2028)
  • Table 203. Artemether Ambrosia Drugs Pvt. (india) , by Region USD Million (2023-2028)
  • Table 204. Artemether Sigmak Lifesciences (india) , by Region USD Million (2023-2028)
  • Table 205. Artemether: by Sales Channels(USD Million)
  • Table 206. Artemether Online Sales Channel {Company Website, E-Commerce Platform} , by Region USD Million (2023-2028)
  • Table 207. Artemether Offline Sales Channels {Company store outlet, and medical Stores} , by Region USD Million (2023-2028)
  • Table 208. Artemether: by Mode of Administration(USD Million)
  • Table 209. Artemether Oral , by Region USD Million (2023-2028)
  • Table 210. Artemether Intravenous Route , by Region USD Million (2023-2028)
  • Table 211. Artemether Intramuscular Route , by Region USD Million (2023-2028)
  • Table 212. Artemether Subcutaneous Route , by Region USD Million (2023-2028)
  • Table 213. Artemether Rectal Route , by Region USD Million (2023-2028)
  • Table 214. Artemether Vaginal Route , by Region USD Million (2023-2028)
  • Table 215. Artemether Inhaled Route , by Region USD Million (2023-2028)
  • Table 216. South America Artemether, by Country USD Million (2023-2028)
  • Table 217. South America Artemether, by Type USD Million (2023-2028)
  • Table 218. South America Artemether, by Sales Channels USD Million (2023-2028)
  • Table 219. South America Artemether, by Mode of Administration USD Million (2023-2028)
  • Table 220. Brazil Artemether, by Type USD Million (2023-2028)
  • Table 221. Brazil Artemether, by Sales Channels USD Million (2023-2028)
  • Table 222. Brazil Artemether, by Mode of Administration USD Million (2023-2028)
  • Table 223. Argentina Artemether, by Type USD Million (2023-2028)
  • Table 224. Argentina Artemether, by Sales Channels USD Million (2023-2028)
  • Table 225. Argentina Artemether, by Mode of Administration USD Million (2023-2028)
  • Table 226. Rest of South America Artemether, by Type USD Million (2023-2028)
  • Table 227. Rest of South America Artemether, by Sales Channels USD Million (2023-2028)
  • Table 228. Rest of South America Artemether, by Mode of Administration USD Million (2023-2028)
  • Table 229. Asia Pacific Artemether, by Country USD Million (2023-2028)
  • Table 230. Asia Pacific Artemether, by Type USD Million (2023-2028)
  • Table 231. Asia Pacific Artemether, by Sales Channels USD Million (2023-2028)
  • Table 232. Asia Pacific Artemether, by Mode of Administration USD Million (2023-2028)
  • Table 233. China Artemether, by Type USD Million (2023-2028)
  • Table 234. China Artemether, by Sales Channels USD Million (2023-2028)
  • Table 235. China Artemether, by Mode of Administration USD Million (2023-2028)
  • Table 236. Japan Artemether, by Type USD Million (2023-2028)
  • Table 237. Japan Artemether, by Sales Channels USD Million (2023-2028)
  • Table 238. Japan Artemether, by Mode of Administration USD Million (2023-2028)
  • Table 239. India Artemether, by Type USD Million (2023-2028)
  • Table 240. India Artemether, by Sales Channels USD Million (2023-2028)
  • Table 241. India Artemether, by Mode of Administration USD Million (2023-2028)
  • Table 242. South Korea Artemether, by Type USD Million (2023-2028)
  • Table 243. South Korea Artemether, by Sales Channels USD Million (2023-2028)
  • Table 244. South Korea Artemether, by Mode of Administration USD Million (2023-2028)
  • Table 245. Australia Artemether, by Type USD Million (2023-2028)
  • Table 246. Australia Artemether, by Sales Channels USD Million (2023-2028)
  • Table 247. Australia Artemether, by Mode of Administration USD Million (2023-2028)
  • Table 248. Rest of Asia-Pacific Artemether, by Type USD Million (2023-2028)
  • Table 249. Rest of Asia-Pacific Artemether, by Sales Channels USD Million (2023-2028)
  • Table 250. Rest of Asia-Pacific Artemether, by Mode of Administration USD Million (2023-2028)
  • Table 251. Europe Artemether, by Country USD Million (2023-2028)
  • Table 252. Europe Artemether, by Type USD Million (2023-2028)
  • Table 253. Europe Artemether, by Sales Channels USD Million (2023-2028)
  • Table 254. Europe Artemether, by Mode of Administration USD Million (2023-2028)
  • Table 255. Germany Artemether, by Type USD Million (2023-2028)
  • Table 256. Germany Artemether, by Sales Channels USD Million (2023-2028)
  • Table 257. Germany Artemether, by Mode of Administration USD Million (2023-2028)
  • Table 258. France Artemether, by Type USD Million (2023-2028)
  • Table 259. France Artemether, by Sales Channels USD Million (2023-2028)
  • Table 260. France Artemether, by Mode of Administration USD Million (2023-2028)
  • Table 261. Italy Artemether, by Type USD Million (2023-2028)
  • Table 262. Italy Artemether, by Sales Channels USD Million (2023-2028)
  • Table 263. Italy Artemether, by Mode of Administration USD Million (2023-2028)
  • Table 264. United Kingdom Artemether, by Type USD Million (2023-2028)
  • Table 265. United Kingdom Artemether, by Sales Channels USD Million (2023-2028)
  • Table 266. United Kingdom Artemether, by Mode of Administration USD Million (2023-2028)
  • Table 267. Netherlands Artemether, by Type USD Million (2023-2028)
  • Table 268. Netherlands Artemether, by Sales Channels USD Million (2023-2028)
  • Table 269. Netherlands Artemether, by Mode of Administration USD Million (2023-2028)
  • Table 270. Rest of Europe Artemether, by Type USD Million (2023-2028)
  • Table 271. Rest of Europe Artemether, by Sales Channels USD Million (2023-2028)
  • Table 272. Rest of Europe Artemether, by Mode of Administration USD Million (2023-2028)
  • Table 273. MEA Artemether, by Country USD Million (2023-2028)
  • Table 274. MEA Artemether, by Type USD Million (2023-2028)
  • Table 275. MEA Artemether, by Sales Channels USD Million (2023-2028)
  • Table 276. MEA Artemether, by Mode of Administration USD Million (2023-2028)
  • Table 277. Middle East Artemether, by Type USD Million (2023-2028)
  • Table 278. Middle East Artemether, by Sales Channels USD Million (2023-2028)
  • Table 279. Middle East Artemether, by Mode of Administration USD Million (2023-2028)
  • Table 280. Africa Artemether, by Type USD Million (2023-2028)
  • Table 281. Africa Artemether, by Sales Channels USD Million (2023-2028)
  • Table 282. Africa Artemether, by Mode of Administration USD Million (2023-2028)
  • Table 283. North America Artemether, by Country USD Million (2023-2028)
  • Table 284. North America Artemether, by Type USD Million (2023-2028)
  • Table 285. North America Artemether, by Sales Channels USD Million (2023-2028)
  • Table 286. North America Artemether, by Mode of Administration USD Million (2023-2028)
  • Table 287. United States Artemether, by Type USD Million (2023-2028)
  • Table 288. United States Artemether, by Sales Channels USD Million (2023-2028)
  • Table 289. United States Artemether, by Mode of Administration USD Million (2023-2028)
  • Table 290. Canada Artemether, by Type USD Million (2023-2028)
  • Table 291. Canada Artemether, by Sales Channels USD Million (2023-2028)
  • Table 292. Canada Artemether, by Mode of Administration USD Million (2023-2028)
  • Table 293. Mexico Artemether, by Type USD Million (2023-2028)
  • Table 294. Mexico Artemether, by Sales Channels USD Million (2023-2028)
  • Table 295. Mexico Artemether, by Mode of Administration USD Million (2023-2028)
  • Table 296. Artemether Sales: by Type(Tons)
  • Table 297. Artemether Sales Micro Orgo Che (india) , by Region Tons (2023-2028)
  • Table 298. Artemether Sales Ambrosia Drugs Pvt. (india) , by Region Tons (2023-2028)
  • Table 299. Artemether Sales Sigmak Lifesciences (india) , by Region Tons (2023-2028)
  • Table 300. Artemether Sales: by Sales Channels(Tons)
  • Table 301. Artemether Sales Online Sales Channel {Company Website, E-Commerce Platform} , by Region Tons (2023-2028)
  • Table 302. Artemether Sales Offline Sales Channels {Company store outlet, and medical Stores} , by Region Tons (2023-2028)
  • Table 303. Artemether Sales: by Mode of Administration(Tons)
  • Table 304. Artemether Sales Oral , by Region Tons (2023-2028)
  • Table 305. Artemether Sales Intravenous Route , by Region Tons (2023-2028)
  • Table 306. Artemether Sales Intramuscular Route , by Region Tons (2023-2028)
  • Table 307. Artemether Sales Subcutaneous Route , by Region Tons (2023-2028)
  • Table 308. Artemether Sales Rectal Route , by Region Tons (2023-2028)
  • Table 309. Artemether Sales Vaginal Route , by Region Tons (2023-2028)
  • Table 310. Artemether Sales Inhaled Route , by Region Tons (2023-2028)
  • Table 311. South America Artemether Sales, by Country Tons (2023-2028)
  • Table 312. South America Artemether Sales, by Type Tons (2023-2028)
  • Table 313. South America Artemether Sales, by Sales Channels Tons (2023-2028)
  • Table 314. South America Artemether Sales, by Mode of Administration Tons (2023-2028)
  • Table 315. Brazil Artemether Sales, by Type Tons (2023-2028)
  • Table 316. Brazil Artemether Sales, by Sales Channels Tons (2023-2028)
  • Table 317. Brazil Artemether Sales, by Mode of Administration Tons (2023-2028)
  • Table 318. Argentina Artemether Sales, by Type Tons (2023-2028)
  • Table 319. Argentina Artemether Sales, by Sales Channels Tons (2023-2028)
  • Table 320. Argentina Artemether Sales, by Mode of Administration Tons (2023-2028)
  • Table 321. Rest of South America Artemether Sales, by Type Tons (2023-2028)
  • Table 322. Rest of South America Artemether Sales, by Sales Channels Tons (2023-2028)
  • Table 323. Rest of South America Artemether Sales, by Mode of Administration Tons (2023-2028)
  • Table 324. Asia Pacific Artemether Sales, by Country Tons (2023-2028)
  • Table 325. Asia Pacific Artemether Sales, by Type Tons (2023-2028)
  • Table 326. Asia Pacific Artemether Sales, by Sales Channels Tons (2023-2028)
  • Table 327. Asia Pacific Artemether Sales, by Mode of Administration Tons (2023-2028)
  • Table 328. China Artemether Sales, by Type Tons (2023-2028)
  • Table 329. China Artemether Sales, by Sales Channels Tons (2023-2028)
  • Table 330. China Artemether Sales, by Mode of Administration Tons (2023-2028)
  • Table 331. Japan Artemether Sales, by Type Tons (2023-2028)
  • Table 332. Japan Artemether Sales, by Sales Channels Tons (2023-2028)
  • Table 333. Japan Artemether Sales, by Mode of Administration Tons (2023-2028)
  • Table 334. India Artemether Sales, by Type Tons (2023-2028)
  • Table 335. India Artemether Sales, by Sales Channels Tons (2023-2028)
  • Table 336. India Artemether Sales, by Mode of Administration Tons (2023-2028)
  • Table 337. South Korea Artemether Sales, by Type Tons (2023-2028)
  • Table 338. South Korea Artemether Sales, by Sales Channels Tons (2023-2028)
  • Table 339. South Korea Artemether Sales, by Mode of Administration Tons (2023-2028)
  • Table 340. Australia Artemether Sales, by Type Tons (2023-2028)
  • Table 341. Australia Artemether Sales, by Sales Channels Tons (2023-2028)
  • Table 342. Australia Artemether Sales, by Mode of Administration Tons (2023-2028)
  • Table 343. Rest of Asia-Pacific Artemether Sales, by Type Tons (2023-2028)
  • Table 344. Rest of Asia-Pacific Artemether Sales, by Sales Channels Tons (2023-2028)
  • Table 345. Rest of Asia-Pacific Artemether Sales, by Mode of Administration Tons (2023-2028)
  • Table 346. Europe Artemether Sales, by Country Tons (2023-2028)
  • Table 347. Europe Artemether Sales, by Type Tons (2023-2028)
  • Table 348. Europe Artemether Sales, by Sales Channels Tons (2023-2028)
  • Table 349. Europe Artemether Sales, by Mode of Administration Tons (2023-2028)
  • Table 350. Germany Artemether Sales, by Type Tons (2023-2028)
  • Table 351. Germany Artemether Sales, by Sales Channels Tons (2023-2028)
  • Table 352. Germany Artemether Sales, by Mode of Administration Tons (2023-2028)
  • Table 353. France Artemether Sales, by Type Tons (2023-2028)
  • Table 354. France Artemether Sales, by Sales Channels Tons (2023-2028)
  • Table 355. France Artemether Sales, by Mode of Administration Tons (2023-2028)
  • Table 356. Italy Artemether Sales, by Type Tons (2023-2028)
  • Table 357. Italy Artemether Sales, by Sales Channels Tons (2023-2028)
  • Table 358. Italy Artemether Sales, by Mode of Administration Tons (2023-2028)
  • Table 359. United Kingdom Artemether Sales, by Type Tons (2023-2028)
  • Table 360. United Kingdom Artemether Sales, by Sales Channels Tons (2023-2028)
  • Table 361. United Kingdom Artemether Sales, by Mode of Administration Tons (2023-2028)
  • Table 362. Netherlands Artemether Sales, by Type Tons (2023-2028)
  • Table 363. Netherlands Artemether Sales, by Sales Channels Tons (2023-2028)
  • Table 364. Netherlands Artemether Sales, by Mode of Administration Tons (2023-2028)
  • Table 365. Rest of Europe Artemether Sales, by Type Tons (2023-2028)
  • Table 366. Rest of Europe Artemether Sales, by Sales Channels Tons (2023-2028)
  • Table 367. Rest of Europe Artemether Sales, by Mode of Administration Tons (2023-2028)
  • Table 368. MEA Artemether Sales, by Country Tons (2023-2028)
  • Table 369. MEA Artemether Sales, by Type Tons (2023-2028)
  • Table 370. MEA Artemether Sales, by Sales Channels Tons (2023-2028)
  • Table 371. MEA Artemether Sales, by Mode of Administration Tons (2023-2028)
  • Table 372. Middle East Artemether Sales, by Type Tons (2023-2028)
  • Table 373. Middle East Artemether Sales, by Sales Channels Tons (2023-2028)
  • Table 374. Middle East Artemether Sales, by Mode of Administration Tons (2023-2028)
  • Table 375. Africa Artemether Sales, by Type Tons (2023-2028)
  • Table 376. Africa Artemether Sales, by Sales Channels Tons (2023-2028)
  • Table 377. Africa Artemether Sales, by Mode of Administration Tons (2023-2028)
  • Table 378. North America Artemether Sales, by Country Tons (2023-2028)
  • Table 379. North America Artemether Sales, by Type Tons (2023-2028)
  • Table 380. North America Artemether Sales, by Sales Channels Tons (2023-2028)
  • Table 381. North America Artemether Sales, by Mode of Administration Tons (2023-2028)
  • Table 382. United States Artemether Sales, by Type Tons (2023-2028)
  • Table 383. United States Artemether Sales, by Sales Channels Tons (2023-2028)
  • Table 384. United States Artemether Sales, by Mode of Administration Tons (2023-2028)
  • Table 385. Canada Artemether Sales, by Type Tons (2023-2028)
  • Table 386. Canada Artemether Sales, by Sales Channels Tons (2023-2028)
  • Table 387. Canada Artemether Sales, by Mode of Administration Tons (2023-2028)
  • Table 388. Mexico Artemether Sales, by Type Tons (2023-2028)
  • Table 389. Mexico Artemether Sales, by Sales Channels Tons (2023-2028)
  • Table 390. Mexico Artemether Sales, by Mode of Administration Tons (2023-2028)
  • Table 391. Artemether: by Type(USD/Units)
  • Table 392. Research Programs/Design for This Report
  • Table 393. Key Data Information from Secondary Sources
  • Table 394. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Artemether: by Type USD Million (2017-2022)
  • Figure 5. Global Artemether: by Sales Channels USD Million (2017-2022)
  • Figure 6. Global Artemether: by Mode of Administration USD Million (2017-2022)
  • Figure 7. South America Artemether Share (%), by Country
  • Figure 8. Asia Pacific Artemether Share (%), by Country
  • Figure 9. Europe Artemether Share (%), by Country
  • Figure 10. MEA Artemether Share (%), by Country
  • Figure 11. North America Artemether Share (%), by Country
  • Figure 12. Global Artemether: by Type Tons (2017-2022)
  • Figure 13. Global Artemether: by Sales Channels Tons (2017-2022)
  • Figure 14. Global Artemether: by Mode of Administration Tons (2017-2022)
  • Figure 15. South America Artemether Share (%), by Country
  • Figure 16. Asia Pacific Artemether Share (%), by Country
  • Figure 17. Europe Artemether Share (%), by Country
  • Figure 18. MEA Artemether Share (%), by Country
  • Figure 19. North America Artemether Share (%), by Country
  • Figure 20. Global Artemether: by Type USD/Units (2017-2022)
  • Figure 21. Global Artemether share by Players 2022 (%)
  • Figure 22. Global Artemether share by Players (Top 3) 2022(%)
  • Figure 23. Global Artemether share by Players (Top 5) 2022(%)
  • Figure 24. BCG Matrix for key Companies
  • Figure 25. Novartis Pharmaceutical Company (Switzerland) Revenue, Net Income and Gross profit
  • Figure 26. Novartis Pharmaceutical Company (Switzerland) Revenue: by Geography 2022
  • Figure 27. Chengdu Chenlv Herb Co.,Ltd. (China) Revenue, Net Income and Gross profit
  • Figure 28. Chengdu Chenlv Herb Co.,Ltd. (China) Revenue: by Geography 2022
  • Figure 29. Cipla (India) Revenue, Net Income and Gross profit
  • Figure 30. Cipla (India) Revenue: by Geography 2022
  • Figure 31. Huvepharma Italia (Italy) Revenue, Net Income and Gross profit
  • Figure 32. Huvepharma Italia (Italy) Revenue: by Geography 2022
  • Figure 33. Sichuan Xieli (China) Revenue, Net Income and Gross profit
  • Figure 34. Sichuan Xieli (China) Revenue: by Geography 2022
  • Figure 35. Shaoxing Hantai Pharma (China) Revenue, Net Income and Gross profit
  • Figure 36. Shaoxing Hantai Pharma (China) Revenue: by Geography 2022
  • Figure 37. DKSH (Switzerland) Revenue, Net Income and Gross profit
  • Figure 38. DKSH (Switzerland) Revenue: by Geography 2022
  • Figure 39. Ipca Labs. (India) Revenue, Net Income and Gross profit
  • Figure 40. Ipca Labs. (India) Revenue: by Geography 2022
  • Figure 41. Vital Laboratories Pvt. Ltd. (India) Revenue, Net Income and Gross profit
  • Figure 42. Vital Laboratories Pvt. Ltd. (India) Revenue: by Geography 2022
  • Figure 43. Global Artemether: by Type USD Million (2023-2028)
  • Figure 44. Global Artemether: by Sales Channels USD Million (2023-2028)
  • Figure 45. Global Artemether: by Mode of Administration USD Million (2023-2028)
  • Figure 46. South America Artemether Share (%), by Country
  • Figure 47. Asia Pacific Artemether Share (%), by Country
  • Figure 48. Europe Artemether Share (%), by Country
  • Figure 49. MEA Artemether Share (%), by Country
  • Figure 50. North America Artemether Share (%), by Country
  • Figure 51. Global Artemether: by Type Tons (2023-2028)
  • Figure 52. Global Artemether: by Sales Channels Tons (2023-2028)
  • Figure 53. Global Artemether: by Mode of Administration Tons (2023-2028)
  • Figure 54. South America Artemether Share (%), by Country
  • Figure 55. Asia Pacific Artemether Share (%), by Country
  • Figure 56. Europe Artemether Share (%), by Country
  • Figure 57. MEA Artemether Share (%), by Country
  • Figure 58. North America Artemether Share (%), by Country
  • Figure 59. Global Artemether: by Type USD/Units (2023-2028)
List of companies from research coverage that are profiled in the study
  • Novartis Pharmaceutical Company (Switzerland)
  • Chengdu Chenlv Herb Co.,Ltd. (China)
  • Cipla (India)
  • Huvepharma Italia (Italy)
  • Sichuan Xieli (China)
  • Shaoxing Hantai Pharma (China)
  • DKSH (Switzerland)
  • Ipca Labs. (India)
  • Vital Laboratories Pvt. Ltd. (India)
Select User Access Type

Key Highlights of Report


Jun 2023 234 Pages 56 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Artemether Market Quantitative research analysis
Global Artemether Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Top performing companies in the Global Artemether market are Novartis Pharmaceutical Company (Switzerland), Chengdu Chenlv Herb Co.,Ltd. (China), Cipla (India), Huvepharma Italia (Italy), Sichuan Xieli (China), Shaoxing Hantai Pharma (China), DKSH (Switzerland), Ipca Labs. (India) and Vital Laboratories Pvt. Ltd. (India), to name a few.
"Chinese Companies has Major Hold on Artemether Manufacturing Market" is seen as one of major influencing trends for Artemether Market during projected period 2022-2028.
Micro Orgo Che (india) segment in Global market to hold robust market share owing to "P. falciparum infection mostly accounted for 99.7 percent estimated in African Region, 50 percent in the South-East Asia Region, 71 percent in the Eastern Mediterranean and 65 percent in the Western Pacific".

Know More About Global Artemether Market Report?

Have a Query? Click Here

Other Related Reports

Abiraterone Acetate Drugs Comprehensive Study by End Users (Hospitals, Specialized Clinics, Diagnostic Centres), Treatment (Chemotherapy, Hormone Therapy, Clinical Trials, Radiotherapy, Others), Dist...
$ 3650
Primary Hepatocytes Comprehensive Study by Type (Human Primary Cells, Animal Primary Cells), End-Use Industry (Hospitals, Clinic Centre, Pharmaceuticals, Research institutes, Diagnostics laboratories...
$ 3500
Nephro Genetic Testing Comprehensive Study by Test (Blood Tests, Urine Tests), End-Use Industries (Hospitals, Clinic Centre, Pharmaceuticals, Research institutes, Diagnostics laboratories), Diagnos...
$ 3450
Long Acting Drug Delivery Comprehensive Study by Injectable (Sterile Liquid and Powder Filling, Lyophilization, Homogenization, Spray Drying), End-Use Industries (Pharmaceuticals, Clinical, Medical ...
$ 3750
Amoxicillin Drug Comprehensive Study by Type (Tablet, Powder for Suspension, Chewable Tablet, Extended Release Tablet, Capsule), Sales Channels (Online Sales Channel {Company Website, E-Commerce Plat...
$ 3750
Zinc Finger Nuclease Technology Comprehensive Study by Application (Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering, Others), End-User (Biotechnology Companies, Pharmaceu...
$ 3450